Scout Investments Inc. raised its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 1.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 42,670 shares of the medical instruments supplier’s stock after buying an additional 600 shares during the period. Scout Investments Inc. owned approximately 0.22% of ICU Medical worth $7,361,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Suntrust Banks Inc. increased its position in ICU Medical by 3.0% in the first quarter. Suntrust Banks Inc. now owns 2,288 shares of the medical instruments supplier’s stock valued at $347,000 after buying an additional 66 shares during the last quarter. Elkfork Partners LLC increased its position in ICU Medical by 1.4% in the first quarter. Elkfork Partners LLC now owns 4,862 shares of the medical instruments supplier’s stock valued at $743,000 after buying an additional 68 shares during the last quarter. US Bancorp DE increased its position in ICU Medical by 16.5% in the first quarter. US Bancorp DE now owns 15,035 shares of the medical instruments supplier’s stock valued at $2,295,000 after buying an additional 2,124 shares during the last quarter. Flinton Capital Management LLC increased its position in ICU Medical by 1.4% in the first quarter. Flinton Capital Management LLC now owns 2,288 shares of the medical instruments supplier’s stock valued at $349,000 after buying an additional 32 shares during the last quarter. Finally, First Trust Advisors LP increased its position in ICU Medical by 42.0% in the first quarter. First Trust Advisors LP now owns 10,188 shares of the medical instruments supplier’s stock valued at $1,556,000 after buying an additional 3,013 shares during the last quarter. Hedge funds and other institutional investors own 78.13% of the company’s stock.

Shares of ICU Medical, Inc. (ICUI) opened at 175.05 on Friday. The company has a market cap of $3.47 billion, a price-to-earnings ratio of 70.10 and a beta of 0.36. The stock has a 50 day moving average of $171.26 and a 200 day moving average of $162.02. ICU Medical, Inc. has a 1-year low of $120.14 and a 1-year high of $176.50.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by $0.06. The company had revenue of $331.51 million during the quarter, compared to analysts’ expectations of $318.30 million. ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. ICU Medical’s revenue for the quarter was up 242.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.15 EPS. On average, equities analysts forecast that ICU Medical, Inc. will post $4.11 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This report was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/09/02/scout-investments-inc-raises-stake-in-icu-medical-inc-icui.html.

Several research analysts have weighed in on the stock. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $193.00 price objective on the stock in a report on Thursday, July 20th. Sidoti downgraded shares of ICU Medical from a “buy” rating to a “neutral” rating in a report on Tuesday, June 20th. BidaskClub downgraded shares of ICU Medical from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Gabelli reiterated a “buy” rating on shares of ICU Medical in a research note on Friday, August 11th. Finally, Roth Capital lowered shares of ICU Medical from a “buy” rating to a “neutral” rating in a research note on Thursday, May 11th. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $193.00.

In other news, Director Robert S. Swinney sold 3,400 shares of ICU Medical stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $175.01, for a total value of $595,034.00. Following the completion of the transaction, the director now owns 15,193 shares of the company’s stock, valued at approximately $2,658,926.93. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Robert S. Swinney sold 4,477 shares of ICU Medical stock in a transaction dated Thursday, July 20th. The stock was sold at an average price of $175.00, for a total value of $783,475.00. Following the completion of the transaction, the director now directly owns 23,293 shares of the company’s stock, valued at approximately $4,076,275. The disclosure for this sale can be found here. In the last ninety days, insiders sold 210,765 shares of company stock valued at $36,043,486. 15.90% of the stock is owned by insiders.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Stock Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related stocks with our FREE daily email newsletter.